Predictions
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€3.49
10.10.21
10.10.21
€5.00
31.12.23
31.12.23
-32.83%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€6.46
04.01.23
04.01.23
€12.00
31.12.25
31.12.25
63.49%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€4.23
28.05.22
28.05.22
-
28.05.23
28.05.23
-56.27%
24.04.23
24.04.23
Probably not worthwhile Investment
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€3.79
20.09.21
20.09.21
-
20.09.25
20.09.25
-26.16%
03.04.23
03.04.23
Could be worthwhile Investment >10% per year
InMed Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€16.34
12.09.22
12.09.22
-
12.09.23
12.09.23
-93.70%
02.04.23
02.04.23
Could be very worthwhile Investment >20% year
InMed Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1.30
20.03.23
20.03.23
-
20.03.24
20.03.24
6.18%
23.03.23
23.03.23
Could be worthwhile Investment >10% per year
Capable Management
Good culture
Little innovation
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€5.37
21.07.22
21.07.22
€5.30
21.07.23
21.07.23
-21.42%
11.03.23
11.03.23
ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Aptose Biosciences
Start price
Target price
Perf. (%)
€0.98
14.12.21
14.12.21
-
14.12.22
14.12.22
-39.08%
15.12.22
15.12.22
Could be worthwhile Investment >10% per year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€4.85
01.12.21
01.12.21
-
01.12.22
01.12.22
-53.67%
02.12.22
02.12.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Stable Large shareholder and/or long term investor
Future proof or reliable business model
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.05
20.09.22
20.09.22
€1.80
20.09.23
20.09.23
36.59%
19.11.22
19.11.22
Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.39
03.08.22
03.08.22
€2.80
03.08.23
03.08.23
-14.19%
20.09.22
20.09.22
Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.85
24.08.22
24.08.22
-
24.08.23
24.08.23
-10.03%
03.09.22
03.09.22
Could be worthwhile Investment >10% per year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€10.81
04.07.22
04.07.22
-
04.07.23
04.07.23
-24.63%
06.08.22
06.08.22
Could be worthwhile Investment >10% per year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.37
28.04.22
28.04.22
€2.00
28.04.23
28.04.23
0.74%
03.08.22
03.08.22
Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.39
08.07.21
08.07.21
-
08.07.22
08.07.22
13.98%
08.07.22
08.07.22
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€9.52
27.05.21
27.05.21
€32.00
27.05.22
27.05.22
-55.61%
28.05.22
28.05.22
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Very Future proof/growth oriented business model
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€4.96
07.03.22
07.03.22
-
07.03.23
07.03.23
27.52%
28.03.22
28.03.22
Could be worthwhile Investment >10% per year
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€13.28
12.03.21
12.03.21
€24.00
12.03.22
12.03.22
-62.26%
12.03.22
12.03.22
Could be very worthwhile Investment >20% year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€17.02
16.02.22
16.02.22
-
16.02.23
16.02.23
-10.26%
19.02.22
19.02.22
Could be worthwhile Investment >10% per year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€14.52
23.01.22
23.01.22
-
23.01.23
23.01.23
7.06%
06.02.22
06.02.22
Could be worthwhile Investment >10% per year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.30
23.01.22
23.01.22
-
23.01.23
23.01.23
15.82%
06.02.22
06.02.22
Risky Investment
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€16.62
14.01.22
14.01.22
-
14.01.23
14.01.23
-12.67%
22.01.22
22.01.22
Could be worthwhile Investment >10% per year
Xenon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€14.20
18.09.21
18.09.21
€40.00
31.12.23
31.12.23
61.97%
16.12.21
16.12.21
Could be very worthwhile Investment >20% year
Aptose Biosciences
Start price
Target price
Perf. (%)
€3.22
11.06.21
11.06.21
€4.00
11.06.22
11.06.22
-69.57%
14.12.21
14.12.21
Could be worthwhile Investment >10% per year
Fennec Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€4.22
29.11.21
29.11.21
-
29.11.22
29.11.22
-16.11%
12.12.21
12.12.21
Could be worthwhile Investment >10% per year